Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Condition:   HIVInterventions:   Drug: HAART;   Drug: HAART + ImmunotherapySponsor:   Juan A. ArnaizCompleted - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials